Lobbying Update: $1,030,000 of CENTENE CORPORATION lobbying was just disclosed

Centene Corporation disclosed $1,030,000 in lobbying expenditures for Q1 2026, focusing on health insurance access, affordability, and Medicare Advantage issues. Insider trading data shows two sales by Kenneth A. Burdick totaling $2.5 million, while institutional investors had mixed activity with some major additions and removals of shares. Analyst ratings for CNC are split, with a median price target of $41.5 from 12 analysts.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin